drugset / Trial / NCT02792153

Estradiol and Fear Extinction in Anorexia Nervosa (AN)

NCT02792153

Phase 1 Withdrawn Johns Hopkins University
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether estrogen may help reduce fear of high calorie-density foods in weight-restored women with Anorexia Nervosa (AN).

Timeline

Start
2016-12
Primary completion
2018-08-22
Completion
2018-08-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified 0.1 mg Other
Background medroxyprogesterone acetate Other / unclassified 2.5 mg Oral

Indications